V. Lemons et al., THE EFFECT OF NIMODIPINE ON HIGH-ENERGY PHOSPHATES AND INTRACELLULAR PH DURING CEREBRAL-ISCHEMIA, Journal of neurotrauma, 10(1), 1993, pp. 73-81
Experimental and clinical studies suggest that the calcium channel blo
cker nimodipine may reduce cerebral ischemic injury. Using rapid acqui
sition phosphorus-31 nuclear magnetic resonance (P-31 NMR) spectroscop
y, we examined the effect of nimodipine on cerebral energy metabolism
during severe ischemia in gerbils. High-energy phosphates and intracel
lular pH were characterized at baseline and at 2-min intervals followi
ng bilateral common carotid artery (CCA) ligation. Serial forebrain sp
ectroscopy was continued until phosphocreatine (PCr) and adenosine tri
phosphate (ATP) resonances disappeared. Controls (n = 10) were compare
d to gerbils receiving intraperitoneal nimodipine 30 min prior to caro
tid ligation, at the following doses: 0.5 mg/kg (n = 8), 1.0 mg/kg (n
= 10), 2.0 mg/kg (n = 8), or 4.0 mg/kg (n = 4). In the control group,
PCr and ATP peaks were undetectable after a mean of 5.4 +/- 0.47 min f
ollowing CCA ligation. Compared with controls, the mean time for deple
tion of high-energy phosphates following carotid ligation was prolonge
d at nimodipine doses of 0.5 mg/kg and 1.0 mg/kg, but the differences
did not reach statistical significance. In the 2.0 mg/kg group, howeve
r, ATP was preserved until 9.8 +/- 1.0 min following the onset of isch
emia, significantly longer than the control group (p = 0.005, Mann-Whi
tney test). Nimodipine had no effect on the time course or severity of
intracellular acidosis. In this model of severe ischemia, relatively
high doses of nimodipine slowed the depletion of high-energy phosphate
s without altering intracellular acidosis. This suggests that nimodipi
ne may provide cerebral protection by directly altering ischemic cellu
lar metabolism.